Setyawan, Yuswanto. “Nilotinib As the First Line Therapy in Managing Chronic Myelogenous Leukemia”. e-CliniC 9, no. 2 (March 21, 2021): 342–350. Accessed December 21, 2024. https://ejournal.unsrat.ac.id/v3/index.php/eclinic/article/view/32699.